Search results

Filters
Close
ADDED DATE
Added date
TOPICS Please select
WATCH / LISTEN / READ TIME
ESC HF 25: TIM-HF2 Pre-specified Analysis
Author(s): Stefan Stork Added: 1 year ago
ESC HF 25 - A secondary analysis of TIM-HF2 showed that patients residing farther from their cardiologist benefited further from remote patient management (RPM).Prof Stefan Störk (University Hospital Wuerzburg, DE) discusses the findings from a pre-specified, secondary analysis of TIM-HF2, investigating the impact of rurality and travel distance on the effectiveness of RPM in patients… View more

Digital Health

Heart Failure
ACC 2025: The CardiAMP-HF Trial
Author(s): Amish Raval Added: 1 year ago
ACC 2025 - Principal results from autologous cell therapy in patients with heart failure with reduced ejection fraction (HFrEF) show favourable safety outcomes, however, the study did not meet its primary efficacy outcome using 6 minute walking rests as 3rd F-S tier.Dr Amish Raval (UW Health University Hospital Interventional Cardiology Clinic, WI, US) joins us onsite at ACC to discuss the… View more

Heart Failure
AHA 24: The ENDEAVOR Trial
Author(s): Added: 1 year ago
AHA Conference 2024 - Primary safety and efficacy results from ENDEAVOR investigating the effect of myeloperoxidase inhibition with mitiperstat (AstraZeneca) on symptoms and exercise capacity in patients with heart failure with preserved or mildly reduced ejection fraction (HFpEF/HFmrEF).Dr Sanjiv Shah (Bluhm Cardiovascular Institute, Chicago, US) joins us onsite at AHA Conference to discuss the… View more

Heart Failure
Clinical Frailty Scale Predicts Mortality in Heart Failure
Added: 5 months ago Source:  Radcliffe Cardiology
Frailty is a common and significant factor associated with adverse outcomes in patients with heart failure, but the prognostic utility of simple assessment tools in contemporary practice remains an area of investigation. A new study using data from a large Japanese registry has found that the Clinical Frailty Scale (CFS) effectively captures both physical and cognitive decline and is an… View more

Prevention & Chronic Conditions

Demographic
Tirzepatide Benefits in HFpEF Consistent Across Obesity Levels, SUMMIT Analysis Shows
Added: 10 months ago Source:  Radcliffe CVRM
A secondary analysis of the SUMMIT trial has found that the benefits of tirzepatide on reducing the risk of cardiovascular death or worsening heart failure (HF) are consistent across all levels of obesity in patients with heart failure with preserved ejection fraction (HFpEF).¹ However, patients with a higher baseline body mass index (BMI) experienced greater improvements in exercise capacity and… View more

Cardiovascular Kidney Metabolic

Heart Failure
GLP-1RAs: Mechanism of Action and Role in HFpEF Management
Author(s): Magdy Abdelhamid , Mostafa M Abdrabou , Emanuel Faris , et al Added: 7 months ago

Heart Failure
ESC 2025 Hot Line & Late-Breaking Collection
Author(s): Joost Daemen , Nicolas M Van Mieghem Added: 10 months ago
Dive into our coverage of ESC Congress 2025 for groundbreaking trial results and discussions with expert faculty.Watch ourView From the Thoraxcenterseries for practice-focused reviews of the most anticipated trials from interventional experts,Prof Nicolas Van MieghemandDr Joost Daemen. Watch our Wrap-Upseries led byDr Mirvat Alasnag summarising the key take-aways from each day of the congress.For… View more

Imaging & Diagnostics

Intervention
HFA 2026: CSP Versus BiV Pacing After AV Node Ablation — CONDUCT-AF
Author(s): David Zizek Added: 3 weeks ago
HFA Congress 2026 — Dr David Žižek (University Medical Centre Ljubljana, Ljubljana, SI) joins us to discuss findings from CONDUCT-AF, a randomised, multicentre trial comparing conduction system pacing (CSP) with biventricular (BiV) pacing following atrioventricular node ablation (AVNA) in heart failure patients with symptomatic atrial fibrillation and narrow QRS.The trial enrolled 82 patients… View more
ACC 26: STEMI-DTU Trial – Primary Unloading and Delayed Reperfusion
Author(s): Navin K Kapur Added: 2 months ago
ACC.26 – Dr Navin Kapur (Tufts Medicine, Boston, MA, US) joins us to discuss findings from the STEMI-Door To Unload (DTU) randomised clinical trial, examining whether primary left ventricular unloading with the Impella CP® device prior to reperfusion can reduce infarct size and heart failure-related outcomes in patients presenting with anterior ST-elevation myocardial infarction.This prospective,… View more

Intervention

Heart Failure